Navigation Links
BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
Date:11/19/2008

BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. delivered the keynote presentation on Wednesday, November 19, at a meeting in Madison, Wisconsin commemorating the 10th anniversary of the publication describing the first derivation and culturing of human embryonic stem cells. Dr. West’s presentation is titled “Opportunities and Challenges of Commercializing Stem Cell Research.” The Wisconsin Academy, along with University of Wisconsin-Madison and the Wisconsin Alumni Research Foundation (WARF), hosted the two-day event titled “A Decade Celebrating Stem Cells: Changing the Face of Medicine Ten Years Later” to commemorate the publication of the first derivation of human embryonic stem cells and to examine future trends.

ALAMEDA, Calif. (Business Wire EON) November 19, 2008 -- Dr. West's presentation included a historical overview of the biotechnology industry, a description of historical trends in the industry of commercializing stem cell technology, and a discussion of future opportunities for the field. Dr. West discussed BioTime's stem cell research program that is focused on opportunities for near-term revenues in the development and marketing of products derived from stem cells.

  • West announced the launch of ten new cell line products and presented data on their unique properties and potential utility in regenerative medicine. The molecular markers of these lines are consistent with varied types of human neural crest, mesodermal, and CNS progenitor cells that have promise for the treatment of numerous diseases such as cranial-facial, muscular, and neurological disorders. Information about these cell lines will be available online at www.embry
    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative
2. Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
3. Vocollect Healthcare Systems Names Michael French as Vice President of Customer Experience
4. UCSF Chancellor J. Michael Bishop Announces Plan To Step Down
5. Majesco Entertainment and Interactive Game Group Announce Jillian Michaels Fitness Ultimatum 2009 Ships to Stores October 21st
6. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
7. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
8. Michael J. Fox Foundation Awards One Million Dollars for Development of Trojan Horse Delivery Technology to Treat Parkinsons Disease
9. Catholic Health East Acquires Saint Michaels Medical Center
10. Michael and Terry Ward Donate $1 Million to Wounded Warrior Project (WWP)
11. Rock The Cradles Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters 
BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
(Date:11/9/2009)...nds to move lab findings into human therapy for di... nerve damage ,, ANN ARBOR, Mich., Nov. 9 /PRN...ity of Michigan Department of Neurology have recei...y for neuropathic pain, a difficult-to-treat condi...damage to nerve without obvious tissue injury. ,...
(Date:11/9/2009)...struction industry, respiratory disease, often lea... is a major public health concern. Studies led by...ia Tech,s School of Construction, have shown that ...ve in reducing the dust that causes these health h...technology remains very low. , To find out why, ...
(Date:11/9/2009)...as might be the reason why African Americans are n...me rate as similar patients in other racial groups...reas transplantation at Georgetown University Hosp...own University Medical Center, and colleagues expl...American Journal of Transplantation . , Medicar...
(Date:11/9/2009)...ership to bring next generation of sports medicine... Colorado Springs, CO and Marin...ted States Olympic Committee (USOC) and D.I.S.C. S...a strategic partnership in which D.I.S.C. will bec...the 2012 Olympic Games. With this agreement D.I.S....
(Date:11/9/2009)...uver Career College launches month-long clothing d...y, BC (Vocus) November 9, 2009 -- The students and...igging through their closets to find clothing to. ... same in order to help women and children in need....community here on campus amongst our students, sta...
Breaking Medicine News(10 mins):Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 2Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 3Health News:Surrey College Students Collect Clothing for Women and Children 2
...tworks, Inc. has announced that it has sold the ri...enaming MyBlackBook.Org, the popular sexual histor... New York, NY (PRWEB) February 5, 2...it,s sexual health service to nOOkist™ ( htt...
...president of American Life League, issued a statem...hbishop Raymond Burke, prefect of the Apostolic Si..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...ve Holy Communion and is not to be given Holy Comm...
... Hospitals of America (PHA) congratulates Congress...de healthcare access and insurance to millions of ...utive Director. "Congress recognized that the SCH...y attached to this important package." , , For th...
...Attorney General Andrew Cuomo and MVP Health Care ...n to establish a new not-for-profit organization t...ment data for use by health insurers who choose to...tate New York based health insurer. The company i...
...t Cigarette Equivalent for First Time , , WASHING...cates a dramatic increase in the use of cigarillos...ng trend given the popularity of these products wi...n increased 240 percent, while cigarillos increase...
...ds, and it affects more youngsters than flu, study...ews) -- It,s called respiratory syncytial virus (R...one of every 13 visits to a pediatrician, and one ...en. And, it,s not just kids with underlying lung ...
Other Medicine News:Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3Health News:American Life League: Vatican Says Bishops Must Refuse Communion to Pro-Abortion Politicians 2Health News:Physician Hospitals of America (PHA) Congratulates Congress on its Passage of a 'Clean' SCHIP Children's Health Bill 2Health News:MVP Health Care is First Upstate New York Based Health Insurer to Agree with Attorney General Andrew Cuomo on Out-Of-Network Provider Payment Reform 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 3Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 4Health News:RSV to Blame for 1 in 13 Pediatrician Visits 2Health News:RSV to Blame for 1 in 13 Pediatrician Visits 3
(Date:11/9/2009)...ewswire/ -- Bend Research Inc., a company,with mor...ve pharmaceutical,technologies to help clients sol...roblems, announced today that it has entered into ...orated, a global biotechnology company,headquarter...ollaboration, Vertex will utilize Bend,s formulati...
(Date:11/9/2009)...wswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT... pathologists, oncologists and the pharmaceutical ...make presentations at two upcoming investor confer...on will be made at the Lazard Capital Markets Sixt...uesday, November 17. The conference will be held a...
(Date:11/7/2009)...wire/ -- Patients reported C1-esterase inhibitor (...ating acute swelling attacks at any body location ...rding to data presented today at the 2009 American...I) Annual Meeting. The results come from a self-re...th the ongoing, prospective, open label I nternat...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Viral Genetics Completes Second Major Debt Conversion 55463 1Viral Genetics Completes Second Major Debt Conversion 55463 2Viral Genetics Completes Second Major Debt Conversion 55463 3Spokane Washington Man Indicted On Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55460 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 2Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 3
...le with Diabetes, Hospital,and Professional Charge...URGH, April 02, 2007 /PRNewswire-FirstCall/ -- The...ced today the,release of a new report on the preva...ype 2 diabetes. The inaugural Pittsburgh Type,2 Di...ient,demographics, hospital and professional charg...
...r 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPR... of Proellex(TM), an oral drug being developed to,...uggests that,treatment with Proellex results in a ...mptoms associated with uterine,fibroids and is gen..., This 12 week, double-blind study compared two do...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: